ID   FLVC1_HUMAN             Reviewed;         555 AA.
AC   Q9Y5Y0; Q1HE16; Q86XY9; Q9NVR9;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   10-MAY-2017, entry version 124.
DE   RecName: Full=Feline leukemia virus subgroup C receptor-related protein 1;
DE            Short=Feline leukemia virus subgroup C receptor;
DE            Short=hFLVCR;
GN   Name=FLVCR1; Synonyms=FLVCR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND
RP   CHARACTERIZATION OF FELV-C RECEPTOR FUNCTION.
RC   TISSUE=Lymphocyte;
RX   PubMed=10400745;
RA   Tailor C.S., Willett B.J., Kabat D.;
RT   "A putative cell surface receptor for anemia-inducing feline leukemia
RT   virus subgroup C is a member of a transporter superfamily.";
RL   J. Virol. 73:6500-6505(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   PRO-52 AND MET-544.
RC   TISSUE=Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   GENE STRUCTURE.
RX   PubMed=11943475; DOI=10.1016/S0378-1119(02)00457-2;
RA   Lipovich L., Hughes A.L., King M.-C., Abkowitz J.L., Quigley J.G.;
RT   "Genomic structure and evolutionary context of the human feline
RT   leukemia virus subgroup C receptor (hFLVCR) gene: evidence for block
RT   duplications and de novo gene formation within duplicons of the hFLVCR
RT   locus.";
RL   Gene 286:203-213(2002).
RN   [7]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=15369674; DOI=10.1016/j.cell.2004.08.014;
RA   Quigley J.G., Yang Z., Worthington M.T., Phillips J.D., Sabo K.M.,
RA   Sabath D.E., Berg C.L., Sassa S., Wood B.L., Abkowitz J.L.;
RT   "Identification of a human heme exporter that is essential for
RT   erythropoiesis.";
RL   Cell 118:757-766(2004).
RN   [8]
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND GLYCOSYLATION.
RX   PubMed=16439531; DOI=10.1128/JVI.80.4.1742-1751.2006;
RA   Brown J.K., Fung C., Tailor C.S.;
RT   "Comprehensive mapping of receptor-functioning domains in feline
RT   leukemia virus subgroup C receptor FLVCR1.";
RL   J. Virol. 80:1742-1751(2006).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH HPX.
RX   PubMed=20610401; DOI=10.1074/jbc.M110.119131;
RA   Yang Z., Philips J.D., Doty R.T., Giraudi P., Ostrow J.D.,
RA   Tiribelli C., Smith A., Abkowitz J.L.;
RT   "Kinetics and specificity of feline leukemia virus subgroup C receptor
RT   (FLVCR) export function and its dependence on hemopexin.";
RL   J. Biol. Chem. 285:28874-28882(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   ALTERNATIVE SPLICING (ISOFORM 2), FUNCTION (ISOFORM 2), AND
RP   SUBCELLULAR LOCATION (ISOFORM 2).
RX   PubMed=23187127; DOI=10.1172/JCI62422;
RA   Chiabrando D., Marro S., Mercurio S., Giorgi C., Petrillo S.,
RA   Vinchi F., Fiorito V., Fagoonee S., Camporeale A., Turco E.,
RA   Merlo G.R., Silengo L., Altruda F., Pinton P., Tolosano E.;
RT   "The mitochondrial heme exporter FLVCR1b mediates erythroid
RT   differentiation.";
RL   J. Clin. Invest. 122:4569-4579(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-536, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   FUNCTION, INVOLVEMENT IN SENSORY NEUROPATHY, AND VARIANTS ARG-192 AND
RP   SER-221.
RX   PubMed=27923065; DOI=10.1371/journal.pgen.1006461;
RA   Chiabrando D., Castori M., di Rocco M., Ungelenk M., Giesselmann S.,
RA   Di Capua M., Madeo A., Grammatico P., Bartsch S., Huebner C.A.,
RA   Altruda F., Silengo L., Tolosano E., Kurth I.;
RT   "Mutations in the heme exporter FLVCR1 cause sensory neurodegeneration
RT   with loss of pain perception.";
RL   PLoS Genet. 12:E1006461-E1006461(2016).
RN   [18]
RP   VARIANTS PCARP ASP-121; ARG-192 AND THR-241.
RX   PubMed=21070897; DOI=10.1016/j.ajhg.2010.10.013;
RA   Rajadhyaksha A.M., Elemento O., Puffenberger E.G., Schierberl K.C.,
RA   Xiang J.Z., Putorti M.L., Berciano J., Poulin C., Brais B.,
RA   Michaelides M., Weleber R.G., Higgins J.J.;
RT   "Mutations in FLVCR1 cause posterior column ataxia and retinitis
RT   pigmentosa.";
RL   Am. J. Hum. Genet. 87:643-654(2010).
RN   [19]
RP   VARIANT PCARP ARG-493.
RX   PubMed=21267618; DOI=10.1007/s10048-010-0271-4;
RA   Ishiura H., Fukuda Y., Mitsui J., Nakahara Y., Ahsan B., Takahashi Y.,
RA   Ichikawa Y., Goto J., Sakai T., Tsuji S.;
RT   "Posterior column ataxia with retinitis pigmentosa in a Japanese
RT   family with a novel mutation in FLVCR1.";
RL   Neurogenetics 12:117-121(2011).
CC   -!- FUNCTION: Isoform 1: Heme transporter that exports cytoplasmic
CC       heme. It can also export coproporphyrin and protoporphyrin IX,
CC       which are both intermediate products in the heme biosynthetic
CC       pathway. Does not export bilirubin. Heme export depends on the
CC       presence of HPX and is required to maintain intracellular free
CC       heme balance, protecting cells from heme toxicity. Heme export
CC       provides protection from heme or ferrous iron toxicities in liver,
CC       brain, sensory neurons and during erythtopoiesis, a process in
CC       which heme synthesis intensifies. Causes susceptibility to FeLV-C
CC       in vitro. {ECO:0000269|PubMed:10400745,
CC       ECO:0000269|PubMed:15369674, ECO:0000269|PubMed:20610401,
CC       ECO:0000269|PubMed:27923065}.
CC   -!- FUNCTION: Isoform 2: Heme transporter that promotes heme efflux
CC       from the mitochondrion to the cytoplasm. Essential for erythroid
CC       differentiation.
CC   -!- SUBUNIT: Interacts with HPX. {ECO:0000269|PubMed:20610401}.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane {ECO:0000250};
CC       Multi-pass membrane protein {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Mitochondrion membrane
CC       {ECO:0000250}; Multi-pass membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=FLVC1a;
CC         IsoId=Q9Y5Y0-1; Sequence=Displayed;
CC       Name=2; Synonyms=FLVC1b, mitochondrial;
CC         IsoId=Q9Y5Y0-2; Sequence=VSP_047866;
CC         Note=Has a probable mitochondrial transit peptide at positions
CC         1-38.;
CC   -!- TISSUE SPECIFICITY: Found all hematopoietic tissues including
CC       peripheral blood lymphocytes. Some expression is found in pancreas
CC       and kidney. {ECO:0000269|PubMed:10400745}.
CC   -!- DEVELOPMENTAL STAGE: Down-regulated in haemopoietic progenitor
CC       cells undergoing differentiation and hemoglobinization. Abundant
CC       in fetal liver. {ECO:0000269|PubMed:15369674}.
CC   -!- PTM: N-Glycosylated. {ECO:0000269|PubMed:16439531}.
CC   -!- DISEASE: Posterior column ataxia with retinitis pigmentosa (PCARP)
CC       [MIM:609033]: A neurodegenerative syndrome beginning in infancy
CC       with areflexia and retinitis pigmentosa. Nyctalopia (night
CC       blindness) and peripheral visual field loss are usually evident
CC       during late childhood or teenage years, with subsequent
CC       progressive constriction of the visual fields and loss of central
CC       retinal function over time. A sensory ataxia caused by
CC       degeneration of the posterior columns of the spinal cord results
CC       in a loss of proprioceptive sensation that is clinically evident
CC       in the second decade of life and gradually progresses. Scoliosis,
CC       camptodactyly, achalasia, gastrointestinal dysmotility, and a
CC       sensory peripheral neuropathy are variable features of the
CC       disease. Affected individuals have no clinical or radiological
CC       evidence of cerebral or cerebellar involvement.
CC       {ECO:0000269|PubMed:21070897, ECO:0000269|PubMed:21267618}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry. Defective neuronal heme transmembrane
CC       export due to FLVCR1 mutations may abrogate the neuroprotective
CC       effects of neuroglobin and initiate an apoptotic cascade that
CC       results in the selective degeneration of photoreceptors in the
CC       neurosensory retina and sensory neurons in the posterior spinal
CC       cord.
CC   -!- DISEASE: Note=Defects in FLVCR1 are a cause of a sensory
CC       neuropathy resulting in pain insensitivity. Patients have
CC       decreased sensing of pain, temperature and touch. Self-injury,
CC       ulcers and amputations are commonly observed in affected
CC       individuals. {ECO:0000269|PubMed:27923065}.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily. Feline
CC       leukemia virus subgroup C receptor (TC 2.A.1.28.1) family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF118637; AAD45243.1; -; mRNA.
DR   EMBL; AK001419; BAA91679.1; -; mRNA.
DR   EMBL; DQ496107; ABF47096.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93374.1; -; Genomic_DNA.
DR   EMBL; BC048312; AAH48312.1; -; mRNA.
DR   CCDS; CCDS1510.1; -. [Q9Y5Y0-1]
DR   RefSeq; NP_054772.1; NM_014053.3. [Q9Y5Y0-1]
DR   UniGene; Hs.7055; -.
DR   ProteinModelPortal; Q9Y5Y0; -.
DR   BioGrid; 118803; 19.
DR   IntAct; Q9Y5Y0; 2.
DR   STRING; 9606.ENSP00000355938; -.
DR   TCDB; 2.A.1.28.1; the major facilitator superfamily (mfs).
DR   iPTMnet; Q9Y5Y0; -.
DR   PhosphoSitePlus; Q9Y5Y0; -.
DR   BioMuta; FLVCR1; -.
DR   DMDM; 46396053; -.
DR   EPD; Q9Y5Y0; -.
DR   PaxDb; Q9Y5Y0; -.
DR   PeptideAtlas; Q9Y5Y0; -.
DR   PRIDE; Q9Y5Y0; -.
DR   Ensembl; ENST00000366971; ENSP00000355938; ENSG00000162769. [Q9Y5Y0-1]
DR   GeneID; 28982; -.
DR   KEGG; hsa:28982; -.
DR   UCSC; uc001hjt.3; human. [Q9Y5Y0-1]
DR   CTD; 28982; -.
DR   DisGeNET; 28982; -.
DR   GeneCards; FLVCR1; -.
DR   HGNC; HGNC:24682; FLVCR1.
DR   HPA; HPA046646; -.
DR   MalaCards; FLVCR1; -.
DR   MIM; 609033; phenotype.
DR   MIM; 609144; gene.
DR   neXtProt; NX_Q9Y5Y0; -.
DR   OpenTargets; ENSG00000162769; -.
DR   Orphanet; 88628; Posterior column ataxia - retinitis pigmentosa.
DR   PharmGKB; PA162388695; -.
DR   eggNOG; KOG2563; Eukaryota.
DR   eggNOG; ENOG410XSTK; LUCA.
DR   GeneTree; ENSGT00530000062892; -.
DR   HOGENOM; HOG000019717; -.
DR   HOVERGEN; HBG051631; -.
DR   InParanoid; Q9Y5Y0; -.
DR   KO; K08220; -.
DR   OMA; VIAFKEK; -.
DR   OrthoDB; EOG091G0FJM; -.
DR   PhylomeDB; Q9Y5Y0; -.
DR   TreeFam; TF314292; -.
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   ChiTaRS; FLVCR1; human.
DR   GeneWiki; FLVCR1; -.
DR   GenomeRNAi; 28982; -.
DR   PRO; PR:Q9Y5Y0; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162769; -.
DR   CleanEx; HS_FLVCR1; -.
DR   ExpressionAtlas; Q9Y5Y0; baseline and differential.
DR   Genevisible; Q9Y5Y0; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015232; F:heme transporter activity; IDA:UniProtKB.
DR   GO; GO:0005215; F:transporter activity; TAS:ProtInc.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; TAS:Reactome.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0048704; P:embryonic skeletal system morphogenesis; IEA:Ensembl.
DR   GO; GO:0030218; P:erythrocyte differentiation; IDA:MGI.
DR   GO; GO:0043249; P:erythrocyte maturation; IEA:UniProtKB-KW.
DR   GO; GO:0060323; P:head morphogenesis; IEA:Ensembl.
DR   GO; GO:0097037; P:heme export; IMP:UniProtKB.
DR   GO; GO:0015886; P:heme transport; IMP:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0006839; P:mitochondrial transport; IDA:MGI.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0046620; P:regulation of organ growth; IEA:Ensembl.
DR   GO; GO:0048536; P:spleen development; IEA:Ensembl.
DR   GO; GO:0055085; P:transmembrane transport; IEA:InterPro.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR020846; MFS_dom.
DR   Pfam; PF07690; MFS_1; 1.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome;
KW   Disease mutation; Erythrocyte maturation; Glycoprotein; Membrane;
KW   Mitochondrion; Neurodegeneration; Neuropathy; Phosphoprotein;
KW   Polymorphism; Receptor; Reference proteome; Retinitis pigmentosa;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    555       Feline leukemia virus subgroup C
FT                                receptor-related protein 1.
FT                                /FTId=PRO_0000084844.
FT   TOPO_DOM      1    107       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    108    128       Helical. {ECO:0000255}.
FT   TOPO_DOM    129    147       Extracellular. {ECO:0000255}.
FT   TRANSMEM    148    168       Helical. {ECO:0000255}.
FT   TOPO_DOM    169    174       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    175    195       Helical. {ECO:0000255}.
FT   TOPO_DOM    196    199       Extracellular. {ECO:0000255}.
FT   TRANSMEM    200    220       Helical. {ECO:0000255}.
FT   TOPO_DOM    221    240       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    241    261       Helical. {ECO:0000255}.
FT   TOPO_DOM    262    275       Extracellular. {ECO:0000255}.
FT   TRANSMEM    276    296       Helical. {ECO:0000255}.
FT   TOPO_DOM    297    331       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    332    352       Helical. {ECO:0000255}.
FT   TOPO_DOM    353    372       Extracellular. {ECO:0000255}.
FT   TRANSMEM    373    393       Helical. {ECO:0000255}.
FT   TOPO_DOM    394    401       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    402    422       Helical. {ECO:0000255}.
FT   TOPO_DOM    423    424       Extracellular. {ECO:0000255}.
FT   TRANSMEM    425    445       Helical. {ECO:0000255}.
FT   TOPO_DOM    446    459       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    460    480       Helical. {ECO:0000255}.
FT   TOPO_DOM    481    490       Extracellular. {ECO:0000255}.
FT   TRANSMEM    491    511       Helical. {ECO:0000255}.
FT   TOPO_DOM    512    555       Cytoplasmic. {ECO:0000255}.
FT   MOD_RES      56     56       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     536    536       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    265    265       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    273    273       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    276       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_047866.
FT   VARIANT      52     52       A -> P (in dbSNP:rs11120047).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_050297.
FT   VARIANT     121    121       N -> D (in PCARP; dbSNP:rs267606820).
FT                                {ECO:0000269|PubMed:21070897}.
FT                                /FTId=VAR_065158.
FT   VARIANT     192    192       C -> R (in PCARP; also found in a patient
FT                                with sensory neuropathy and pain
FT                                insensitivity; dbSNP:rs267606821).
FT                                {ECO:0000269|PubMed:21070897,
FT                                ECO:0000269|PubMed:27923065}.
FT                                /FTId=VAR_065159.
FT   VARIANT     221    221       P -> S (probable disease-associated
FT                                mutation found in a patient with sensory
FT                                neuropathy and pain insensitivity;
FT                                dbSNP:rs753000469).
FT                                {ECO:0000269|PubMed:27923065}.
FT                                /FTId=VAR_077884.
FT   VARIANT     241    241       A -> T (in PCARP; dbSNP:rs267606819).
FT                                {ECO:0000269|PubMed:21070897}.
FT                                /FTId=VAR_065160.
FT   VARIANT     493    493       G -> R (in PCARP).
FT                                {ECO:0000269|PubMed:21267618}.
FT                                /FTId=VAR_065161.
FT   VARIANT     544    544       T -> M (in dbSNP:rs3207090).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_050298.
SQ   SEQUENCE   555 AA;  59863 MW;  D0EBA9886CC8E747 CRC64;
     MARPDDEEGA AVAPGHPLAK GYLPLPRGAP VGKESVELQN GPKAGTFPVN GAPRDSLAAA
     SGVLGGPQTP LAPEEETQAR LLPAGAGAET PGAESSPLPL TALSPRRFVV LLIFSLYSLV
     NAFQWIQYSI ISNVFEGFYG VTLLHIDWLS MVYMLAYVPL IFPATWLLDT RGLRLTALLG
     SGLNCLGAWI KCGSVQQHLF WVTMLGQCLC SVAQVFILGL PSRIASVWFG PKEVSTACAT
     AVLGNQLGTA VGFLLPPVLV PNTQNDTNLL ACNISTMFYG TSAVATLLFI LTAIAFKEKP
     RYPPSQAQAA LQDSPPEEYS YKKSIRNLFK NIPFVLLLIT YGIMTGAFYS VSTLLNQMIL
     TYYEGEEVNA GRIGLTLVVA GMVGSILCGL WLDYTKTYKQ TTLIVYILSF IGMVIFTFTL
     DLRYIIIVFV TGGVLGFFMT GYLPLGFEFA VEITYPESEG TSSGLLNASA QIFGILFTLA
     QGKLTSDYGP KAGNIFLCVW MFIGIILTAL IKSDLRRHNI NIGITNVDVK AIPADSPTDQ
     EPKTVMLSKQ SESAI
//
